Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05736770
Other study ID # Riphah/RCRS/REC/ 01378
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2023
Est. completion date August 21, 2023

Study information

Verified date August 2023
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the effects of conventional preoperative respiratory rehabilitation and specific preoperative respiratory rehabilitation program on pulmonary functions in coronary artery bypass graft patients.


Description:

After cardiac surgeries many postoperative changes occur that lead to pulmonary complication such as respiratory changes, functional capacity of lungs and gaseous changes that leads to hypoxemia and ischemic injury of lungs. CABG, although a successful procedure, post operative pulmonary complications still pursue a big challenge to the health and fitness of the patients. Although post operative complications have been managed in in-patient setup post CABG, there are pre-operative measures on the rise to prevent the complications to occur after CABG. This study will contribute in describing the rate of improvement in pulmonary functions with rehabilitation program including preoperative out of bed mobilization, active cycle breathing techniques, forced expiratory technique and volume-based incentive spirometry as compared to the conventional treatment of flow-based incentive spirometry and chest percussion in prevention of post operative pulmonary complications occurring after CABG leading to delayed recovery of patients.


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date August 21, 2023
Est. primary completion date June 10, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - Patients undergoing elective Coronary Artery Bypass Grafting (CABG) surgery for Triple vessel coronary artery disease (TVCAD), double vessel coronary artery disease (DVCAD), single vessel coronary artery disease (SVCAD) and left main stem (LMS) disease. - Patients who cover at least 400 steps on 6-minute walk test. - Patients with ejection fraction 45% or more Exclusion Criteria: - Acute ailments i.e., patient's cardiac condition deteriorating. - Cardiac emergency (shock, acute MI) - Presence of neurological disorders e.g., altered state of consciousness, paralysis. - Redo surgeries - Any musculoskeletal disorder e.g., amputation of limb, problems of balance and risks of fall, muscles weakness grade 3 or less, osteoporosis; leading to limitation in exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Respiratory rehabilitation and out of bed mobilization
The Respiratory rehabilitation and out of bed mobilization group will perform following exercises: pre operative out of bed mobilization, active cycle breathing techniques, forced expiratory technique and volume based incentive spirometery
conventional treatment
The conventional exercise program group will perform :Flow based Incentive spirometery, Chest percussion if needed

Locations

Country Name City State
Pakistan Muhammad ali awan Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Forced expiratory volume in one second (FEV1) The Forced Expiratory Volume in 1 Second parameter measures the volume of air that was exhaled into the mouthpiece in the first second after a full inhalation. The normal test values range between 80% and 120% of the average (predicted) values. 4th postoperative day of coronary artery bypass graft (CABG)
Primary Forced Vital Capacity (FVC) Forced Vital Capacity measures the total volume of air that you were able to blow forcefully into the mouthpiece following a full inhalation 4th postoperative day of coronary artery bypass graft (CABG)
Primary Ratio of Forced expiratory volume in 1 second and Forced Vital Capacity (FEV1/FVC) FEV1/FVC: The FEV1/FVC Ratio (FEV1%) parameter is calculated by dividing the measured FEV1 value by the measured FVC value. In healthy adults of the same gender, height, and age, the normal Predicted percentage should be between 70% and 85. 4th postoperative day of coronary artery bypass graft (CABG)
Secondary 6-minute walk test (6MWT) six minutes walk test (6MWT) is test used to measure functional exercise capacity of patients with cardiovascular and/or pulmonary disease. In this test, patient performs walk for 6 minutes while time being counted on stopwatch. The patient can take rest between the walk, but the timer keeps on running and the rest period is counted. At the end of the test, patient's level of exertion is noted, and the distance measured is recorded. The 6MWT distance values for a healthy person are 400-700m. 4th postoperative day of coronary artery bypass graft (CABG)
Secondary Borg scale The Borg Rating of Perceived Exertion (RPE) scale is a tool for measuring an individual's effort and exertion, breathlessness and fatigue during physical work. Patients are asked to tell the whole feeling of exertion including leg pain and shortness of breath and it is marked on a number from 6-20, where 6 indicates "no exertion at all" and 20 indicates "maximal exertion". 4th postoperative day of coronary artery bypass graft (CABG)
See also
  Status Clinical Trial Phase
Completed NCT04279002 - Association of Psycho-social Traits for the Benefit of a First Respiratory Rehabilitation Course - Exploratory Study.
Recruiting NCT04382534 - A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction
Recruiting NCT05007457 - The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial N/A
Recruiting NCT05299385 - The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) Phase 3
Completed NCT05630079 - Variation of Atelectasis Score After High-frequency Percussions in Severe Acquired Brain Injury